Definium Therapeutics, Inc. Stock-Based Compensation
Definium Therapeutics, Inc. (DFTX) reported Stock-Based Compensation of $9.64 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-06
- Definium Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $9.64M, a 83.50% increase year-over-year.
- Definium Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $7.13M, a 108.17% increase year-over-year.
- Definium Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $5.60M, a 41.69% increase year-over-year.
- Definium Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $5.82M, a 51.42% increase year-over-year.
- Definium Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2025 was $20.10M, a 18.82% increase from fiscal 2024.
- Definium Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2024 was $16.91M, a 11.39% increase from fiscal 2023.
- Definium Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2023 was $15.18M, a 10.77% increase from fiscal 2022.
- Definium Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2022 was $13.71M, a 67.91% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 7 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $9.64M 10-Q · filed 2026-08-06 | $16.77M 10-Q · filed 2026-08-06 | $22.37M derived: sum of 3 quarters · filed 2026-08-06 | $28.19M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2026-03-31 | $7.13M 10-Q · filed 2026-05-07 | $12.73M derived: sum of 2 quarters · filed 2026-05-07 | $18.55M derived: sum of 3 quarters · filed 2026-05-07 | $23.80M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-12-31 | $5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.42M derived: sum of 2 quarters · filed 2026-02-26 | $16.67M derived: sum of 3 quarters · filed 2026-08-06 | $20.10M 10-K · filed 2026-02-26 | |||||
| 2025-09-30 | $5.82M 10-Q · filed 2025-11-06 | $11.07M derived: sum of 2 quarters · filed 2026-08-06 | $14.49M 10-Q · filed 2025-11-06 | $18.45M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-06-30 | $5.25M 10-Q · filed 2026-08-06 | $8.68M 10-Q · filed 2026-08-06 | $12.63M derived: sum of 3 quarters · filed 2026-08-06 | $16.47M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-03-31 | $3.43M 10-Q · filed 2026-05-07 | $7.38M derived: sum of 2 quarters · filed 2026-05-07 | $11.22M derived: sum of 3 quarters · filed 2026-05-07 | $16.65M derived: sum of 4 quarters · filed 2026-05-07 | |||||
| 2024-12-31 | $3.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $7.79M derived: sum of 2 quarters · filed 2026-02-26 | $13.22M derived: sum of 3 quarters · filed 2026-02-26 | $16.91M 10-K · filed 2026-02-26 | |||||
| 2024-09-30 | $3.84M 10-Q · filed 2025-11-06 | $3.77M 10-Q · filed 2024-11-07 | $9.27M derived: sum of 2 quarters · filed 2025-11-06 | $12.96M 10-Q · filed 2025-11-06 | $13.47M 10-Q · filed 2024-11-07 | $16.32M derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | $5.43M 10-Q · filed 2025-07-31 | $5.23M 10-Q · filed 2024-08-13 | $9.12M 10-Q · filed 2025-07-31 | $9.70M 10-Q · filed 2024-08-13 | $12.48M derived: sum of 3 quarters · filed 2025-07-31 | $16.71M derived: sum of 4 quarters · filed 2025-07-31 | |||
| 2024-03-31 | $3.69M 10-Q · filed 2025-05-08 | $4.47M 10-Q · filed 2024-05-08 | $7.05M derived: sum of 2 quarters · filed 2025-05-08 | $11.28M derived: sum of 3 quarters · filed 2025-05-08 | $15.12M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $3.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $7.59M derived: sum of 2 quarters · filed 2025-03-06 | $11.43M derived: sum of 3 quarters · filed 2025-03-06 | $15.18M 10-K · filed 2025-03-06 | $15.49M 10-K · filed 2024-02-28 | ||||
| 2023-09-30 | $4.23M 10-Q · filed 2024-11-07 | $8.07M derived: sum of 2 quarters · filed 2024-11-07 | $11.82M 10-Q · filed 2024-11-07 | $13.19M derived: sum of 4 quarters · filed 2024-11-07 | |||||
| 2023-06-30 | $3.84M 10-Q · filed 2024-08-13 | $7.59M 10-Q · filed 2024-08-13 | $8.97M derived: sum of 3 quarters · filed 2024-08-13 | $13.25M derived: sum of 4 quarters · filed 2024-08-13 | |||||
| 2023-03-31 | $3.75M 10-Q · filed 2024-05-08 | $5.13M derived: sum of 2 quarters · filed 2024-05-08 | $9.41M derived: sum of 3 quarters · filed 2024-05-08 | $13.66M derived: sum of 4 quarters · filed 2024-05-08 | |||||
| 2022-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $5.66M derived: sum of 2 quarters · filed 2024-02-28 | $9.91M derived: sum of 3 quarters · filed 2024-02-28 | $13.71M 10-K · filed 2024-02-28 | |||||
| 2022-09-30 | $4.29M 10-Q · filed 2023-11-02 | $8.54M derived: sum of 2 quarters · filed 2023-11-02 | $12.33M 10-Q · filed 2023-11-02 | $16.67M derived: sum of 4 quarters · filed 2023-11-02 | |||||
| 2022-06-30 | $4.25M 10-Q · filed 2023-08-03 | $8.04M 10-Q · filed 2023-08-03 | $12.39M derived: sum of 3 quarters · filed 2023-08-03 | $16.49M derived: sum of 4 quarters · filed 2023-08-03 | |||||
| 2022-03-31 | $3.79M 10-Q · filed 2023-05-04 | $8.13M derived: sum of 2 quarters · filed 2023-05-04 | $12.24M derived: sum of 3 quarters · filed 2023-05-04 | $45.23M derived: sum of 4 quarters · filed 2023-05-04 | |||||
| 2021-12-31 | $4.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $8.45M derived: sum of 2 quarters · filed 2023-03-09 | $41.44M derived: sum of 3 quarters · filed 2023-03-09 | $42.72M 10-K · filed 2023-03-09 | |||||
| 2021-09-30 | $4.11M 10-Q · filed 2022-11-10 | $37.09M derived: sum of 2 quarters · filed 2022-11-10 | $38.37M 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | $32.99M 10-Q · filed 2022-08-11 | $8.04M 10-Q · filed 2023-08-03 | $34.27M 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | $1.28M 10-Q · filed 2022-05-16 | ||||||||
| 2020-12-31 | $7.41M 10-K · filed 2022-03-28 | ||||||||
| 2019-12-31 | $73.00K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |